Uncommon Cures is a clinical research organization that centralizes high-risk clinical operations while decentralizing low-risk processes, utilizing a telehealth platform and remote monitoring to enhance patient participation in rare disease trials. By streamlining the clinical trial lifecycle, the company reduces costs and accelerates the development of effective therapies for patients with rare diseases.
Funding
Funding not disclosed
Founders
Product
Problem
Conducting clinical trials for rare diseases is challenging due to limited patient populations, geographically dispersed study participants, and the need for specialized expertise, leading to high costs and slow development of effective therapies. Traditional clinical trial models often struggle to efficiently manage both high-risk and low-risk operational aspects, hindering patient participation and delaying trial completion.
Solution
Uncommon Cures is a clinical research organization (CRO) that accelerates rare disease therapeutic development by centralizing high-risk clinical operations within specialized facilities while decentralizing low-risk processes through telehealth and remote monitoring. This dual approach streamlines the clinical trial lifecycle, reduces costs, and enhances patient participation. By leveraging a centralized facility near major medical centers and offering on-site accommodations, Uncommon Cures facilitates intensive monitoring and specialized care. Simultaneously, the company employs remote technologies to extend trial access to patients in their homes, improving convenience and data collection frequency.
Target Audience
Uncommon Cures serves pharmaceutical and biotechnology companies focused on developing therapies for rare diseases, as well as patients and advocacy groups seeking to accelerate clinical research.
Features
- Centralized facilities for high-risk clinical operations, providing comprehensive on-site services and patient accommodations
- Decentralized, home-based solutions for low-risk clinical operations, utilizing telehealth and remote patient monitoring via wearable devices
- On-schedule and on-demand laboratory and diagnostic home delivery services
- Immediate secure connection to cloud-based electronic medical record (EMR) systems
- Expertise in rare disease study design, data collection, and subject screening
- Management of post-marketing studies to monitor long-term safety and efficacy
- Single contract, single IRB, single PI, and single team approach for streamlined management